Search

Your search keyword '"Jung, Yongsik"' showing total 221 results

Search Constraints

Start Over You searched for: Author "Jung, Yongsik" Remove constraint Author: "Jung, Yongsik"
221 results on '"Jung, Yongsik"'

Search Results

5. Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study

7. AI-driven robotic chemist for autonomous synthesis of organic molecules

8. Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor–Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial

10. Improving Electroluminescence of Two‐Coordinate Au(I) Complexes: Insights into Steric and Electronic Control.

11. Relationship between sex hormones levels and 18F-FDG uptake by the ovaries in premenopausal woman

21. Adding ovarian function suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or resume menstruation after chemotherapy: 8-year follow-up of the randomized ASTRRA trial.

22. Breast density reduction as a predictor for prognosis in premenopausal women with hormone receptor–positive breast cancer: A retrospective analysis of the ASTRRA study.

23. Abstract OT1-04-02: The NAUTILUS trial (No Axillary sUrgical Treatment In clinically Lymph node negative patients after UltraSonography): A prospective multicenter randomized phase III trial (NCT04303715)

24. Direct identification of interfacial degradation in blue phosphorescent OLEDs using nanoscale chemical depth profiling

29. Axillary Lymph Node Dissection Rates and Prognosis From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer

30. Protecting Benzylic CH Bonds by Deuteration Doubles the Operational Lifetime of Deep‐Blue Ir‐Phenylimidazole Dopants in Phosphorescent OLEDs (Advanced Optical Materials 16/2021)

31. The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study

32. Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer

33. Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study

36. Cohosts with efficient host-to-emitter energy transfer for stable blue phosphorescent organic light-emitting diodes

37. Clinical Outcomes Following Letrozole Treatment according to Estrogen Receptor Expression in Postmenopausal Women: LETTER Study (KBCSG-006)

40. Protecting benzylic C–H bonds by deuteration doubles the operational lifetime of deep blue Ir-phenylimidazole dopants in phosphorescent OLEDs

41. Blue Phosphorescent OLEDs: Improved Efficiency and Stability of Blue Phosphorescent Organic Light Emitting Diodes by Enhanced Orientation of Homoleptic Cyclometalated Ir(III) Complexes (Advanced Optical Materials 22/2020)

42. Improved Efficiency and Stability of Blue Phosphorescent Organic Light Emitting Diodes by Enhanced Orientation of Homoleptic Cyclometalated Ir(III) Complexes

43. Similar negative emotional impact on hair loss in neoadjuvant endocrine therapy compared to neoadjuvant chemotherapy in young women with breast cancer from patient reported outcomes.

47. Phase II randomized study of neoadjuvant metformin plus letrozole versus placebo plus letrozole for ER-positive postmenopausal breast cancer [METEOR Study].

48. Predicting Phosphorescence Quantum Yield for Pt(II)-Based OLED Emitters from Correlation Function Approach

50. Effect of Gold(I) on the Room‐Temperature Phosphorescence of Ethynylphenanthrene.

Catalog

Books, media, physical & digital resources